Leap Therapeutics, Inc. (LPTX)

NASDAQ: LPTX · IEX Real-Time Price · USD

2.800

-0.160 (-5.41%)

At close: Apr 19, 2024, 4:00 PM

3.000

+0.200 (7.14%)

After-hours: Apr 19, 2024, 7:26 PM EDT

Leap Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	71.61	66.61	115.21	53.05	4.99	17.66	25.74	0.79	0.41	10.87
Short-Term Investments	0	0	0	0	0	0	0	0	0	35.31
Cash & Cash Equivalents	71.61	66.61	115.21	53.05	4.99	17.66	25.74	0.79	0.41	46.18
Cash Growth	7.51%	-42.19%	117.17%	963.15%	-71.75%	-31.37%	3145.52%	95.80%	-99.12%	-
Receivables	0.77	2.1	1.19	0.07	0.19	0.84	1.74	3.05	0	0.54
Other Current Assets	-0.78	-0.76	0.48	-0.85	-0.93	-1.18	0.18	0.18	0.09	0
Total Current Assets	71.6	67.95	116.87	52.27	4.24	17.32	27.66	4.03	0.49	46.72
Property, Plant & Equipment	0.26	0.69	0.5	0.59	1.15	0.09	0.14	0.12	0	0.45
Long-Term Investments	0	0	0	0	0	0	0	0	0	1.26
Goodwill and Intangibles	0	0	0	0	0	0	0	0	0	0.28
Other Long-Term Assets	0.97	1.71	0.54	1.5	2.06	1.67	1.27	2.31	0.77	0
Total Long-Term Assets	1.23	2.4	1.04	2.1	3.21	1.75	1.4	2.43	0.77	1.98
Total Assets	72.83	70.35	117.91	54.37	7.45	19.07	29.06	6.46	1.26	48.7
Accounts Payable	6.47	5.66	4.19	2.72	4.57	3.58	2.62	3.23	2.05	2.49
Deferred Revenue	0	0	0	1.5	0	0	0	0	0	0
Current Debt	0	0	0	0	0	0	0	30.27	3.14	0
Other Current Liabilities	6.22	5.57	5.8	3.16	3.92	2.87	3.46	2.66	0.48	0
Total Current Liabilities	12.68	11.23	9.99	7.37	8.49	6.45	6.08	36.16	5.67	2.49
Long-Term Debt	0	0.26	0.04	0.14	0.55	0	0	0	0	0
Other Long-Term Liabilities	0	0	0	0.2	0.16	3.45	11.86	0	65.88	0
Total Long-Term Liabilities	0	0.26	0.04	0.35	0.71	3.45	11.86	0	65.88	0
Total Liabilities	12.68	11.49	10.02	7.72	9.2	9.9	17.95	36.16	71.55	2.49
Total Debt	0	0.26	0.04	0.14	0.55	0	0	30.27	3.14	0
Debt Growth	-	608.11%	-74.31%	-73.91%	-	-	-	863.83%	-	-
Retained Earnings	-399.58	-318.17	-263.57	-222.99	-195.17	-153.54	-130.4	-100.67	-70.39	-68.2
Comprehensive Income	0.11	0.13	-0.27	-0.58	0.08	0.3	-0.27	0.29	-0	0
Shareholders' Equity	60.14	58.87	107.89	46.65	-1.75	9.18	11.12	-100.23	-70.29	46.21
Net Cash / Debt	71.61	66.35	115.17	52.91	4.44	17.66	25.74	-29.48	-2.74	46.18
Net Cash / Debt Growth	7.93%	-42.39%	117.69%	1092.14%	-74.88%	-31.37%	-	-	-	-
Net Cash Per Share	3.50	5.86	13.42	8.92	1.97	12.26	28.01	-	-	-
Working Capital	58.91	56.73	106.89	44.9	-4.25	10.87	21.58	-32.13	-5.17	44.23
Book Value Per Share	2.94	5.20	12.57	7.86	-0.77	6.49	12.13	-106.72	-74.84	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).